Catalyst
Slingshot members are tracking this event:
Phase 2/3 data of Biohaven's (BHVN) TRORILUZOLE in Generalized anxiety disorder (GAD) due early-1Q 2020
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BHVN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2020
Occurred Source:
https://www.biohavenpharma.com/investors/news-events/press-releases/02-10-2020
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Troriluzole, Anxiety Disorders, Generalized Anxiety Disorder
